| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33512003_HAS_TOPIC_C0079189> <https://research.tib.eu/covid-19/entity/33512003_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33512003_HAS_TOPIC_C0524785> <https://research.tib.eu/covid-19/entity/33512003_HAS_TOPIC_C0679809> <https://research.tib.eu/covid-19/entity/33512003_HAS_TOPIC_C0687742> <https://research.tib.eu/covid-19/entity/33512003_HAS_TOPIC_C0814767> <https://research.tib.eu/covid-19/entity/33512003_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33512003_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33512003_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Division of Pharmacology, Department of Neuroscience, University of Naples \'Federico II\', Naples, Italy.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Cataldi_Mauro> <https://research.tib.eu/covid-19/entity/Pignataro_Giuseppe> <https://research.tib.eu/covid-19/entity/Taglialatela_Maurizio>
?:doi	10.1111/bph.15397
?:doi	<https://research.tib.eu/covid-19/entity/10.1111/bph.15397>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	British journal of pharmacology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33512003>
?:pmid	<https://research.tib.eu/covid-19/entity/33512003>
?:pmid	33512003
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	2.603
?:rankingScore_hIndex	186
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0013227_INTERACTS_WITH_C0079189> <https://research.tib.eu/covid-19/entity/C0013227_TREATS_C0012634>
?:title	Neurological risks and benefits of cytokine-based treatments in coronavirus disease 2019: from preclinical to clinical evidence.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33512003>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33512003>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all